Globus Medical director exercises options, sells 25K shares
Globus Medical director David D. Davidar reported an exercise-and-sell transaction in Class A common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Globus Medical director David D. Davidar reported an exercise-and-sell transaction in Class A common stock. He exercised stock options for 25,000 shares at $26.27 per share and sold 25,000 shares in an open-market transaction at a weighted average price of $80.7629 per share.
Following these moves, Davidar directly holds 510,175 shares of Class A common stock. In addition, a family irrevocable trust established on August 6, 2009 holds 165,967 shares for the benefit of his spouse and children, with his spouse serving as trustee.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 25,000 | $26.27 | $657K |
| Sale | Class A Common Stock | 25,000 | $80.7629 | $2.02M |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
- F2. These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
- F3. These options were granted on January 30, 2017 and are fully vested.
Key Figures
Key Terms
weighted average price financial
open-market sale financial
Stock Option (Right to Buy Class A Common Stock) financial
irrevocable trust financial
fully vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Globus Medical (GMED) director David D. Davidar report in this Form 4?
What stock options did Davidar exercise in this Globus Medical (GMED) filing?
What are Davidar’s direct and indirect Globus Medical (GMED) holdings after the transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.